Public Meeting Notice  Board of Registration in Pharmacy meeting — May 4, 2023

Overview   of Board of Registration in Pharmacy meeting — May 4, 2023

This meeting is open to the public by Webex or telephone.

Join by Webex

• https://eohhs.webex.com/eohhs/j.php?MTID=m13e30e4035b800ed5f3ea69e6d3518a9

Join by telephone

•  +1-617-315-0704 United States Toll (Boston)
• +1-650-479-3208 United States Toll
• Access code: 2531 420 0196

Agenda

Item #	Item
I	Call to order
II	Approval of agenda
III	Approval of Board Minutes Draft of April 6, 2023 regular session minutes
IV	Reports Applications approved pursuant to Licensure Policy 13-01 Monthly report from Probation Board Delegated Review pursuant to Licensure Policy 14-02 PSUD Report-Policy 17-03
V	Flex Pharmacy issues related to COVID-19 PSUD Program Update Cornerstone Health Solutions Central Fill Pilot Project Report Request for additional location Guidance Implementing Executive Order 609 Regarding Reproductive Health Medications Pharmacy Advisory Committee Meeting Update Pharmacy Advisory Committee summary and discussion on Compounded Ketamine Nasal Spray
VI	Application HMC Pharmacy; DS90414 — Waivers Vital Care; DS90415 — Waivers
VII	Policies Staff Action Policy 14-01: Individual Licensure Applications Requiring Good Moral Character Evaluation Policy 2023-07: Non-Sterile Compounding Policy 2023-06: Schedules II and III Quantity Limits Policy 2023-03: COVID-19 Control Measures Policy 2023-02: Vaccine Administration Pharmacy Practice Updates
VIII	Policy Rescissions Policy 2020-11: Vaccine Administration Policy 2020-12: Vaccine Administration by Qualified Pharmacy Technicians Policy 2020-14: COVID-19 Testing Policy 2022-05: COVID-19 Vaccine Administration by Qualified Pharmacy Personnel Policy 2022-06: COVID-19 Therapeutics
IX	Reconsideration CVS 7140; DS89729: PHA-2020-0070
X	File Review 1 CAS-2022-1380 PHA-2022-0209 Rite Aid #10209, DS2899 2 CAS-2023-0018 SA-INV-21359 Holly Mattoes, PH232472 3 CAS-2023-0042 PHA-2023-0022 West Concord Pharmacy, DS3607 4 CAS-2022-1294 PHA-2023-0013 G Medical LLC dba Pharmaceutics, WD488 5 CAS-2022-1022 PHA-2022-0174 Walgreens #9538, DS3474 6 CAS-2022-1568 PHA-2023-0001 Walgreens #4072, DS2788 7 CAS-2023-0173 PHA-2023 -0036 CVS #672, DS89987 8 CAS-2023-0123 PHA-2023-0035 CVS #155, DS2471 9 CAS-2023-0129 PHA-2023-0031 CVS #1868, DS3518 10 CAS-2022-1382 PHA-2022-0211 CVS #1859, DS2945
	Lunch Break
XI	Executive Session The Board will meet in Executive Session as authorized pursuant to M.G.L. c. 30A, § 21(a)(1) for the purpose of discussing the reputation, character, physical condition, or mental health, rather than professional competence, of an individual, or to discuss the discipline or dismissal of, or complaints or charges brought against, a public officer, employee, staff member or individual. Specifically, to evaluate the Good Moral Character as required for registration for a pending applicant.
XII	M.G.L. c. 112, § 65C Session
XIII	Adjournment